94 related articles for article (PubMed ID: 11090281)
1. Structural homology between DNA binding sites of DNA polymerase beta and DNA topoisomerase II.
Mizushina Y; Sugawara F; Iida A; Sakaguchi K
J Mol Biol; 2000 Dec; 304(3):385-95. PubMed ID: 11090281
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structural model analysis of the binding site of lithocholic acid, an inhibitor of DNA polymerase beta and DNA topoisomerase II.
Mizushina Y; Kasai N; Sugawara F; Iida A; Yoshida H; Sakaguchi K
J Biochem; 2001 Nov; 130(5):657-64. PubMed ID: 11686928
[TBL] [Abstract][Full Text] [Related]
3. Structural relationship of lithocholic acid derivatives binding to the N-terminal 8-kDa domain of DNA polymerase beta.
Mizushina Y; Kasai N; Miura K; Hanashima S; Takemura M; Yoshida H; Sugawara F; Sakaguchi K
Biochemistry; 2004 Aug; 43(33):10669-77. PubMed ID: 15311928
[TBL] [Abstract][Full Text] [Related]
4. [Structural homology between molecular probes binding site of DNA polymerase beta and DNA topoisomerase II].
Mizushina Y; Kasai N; Sugawara F; Sakaguchi K
Tanpakushitsu Kakusan Koso; 2002 May; 47(6):708-14. PubMed ID: 11995338
[No Abstract] [Full Text] [Related]
5. Site-directed mutational analysis of structural interactions of low molecule compounds binding to the N-terminal 8 kDa domain of DNA polymerase beta.
Murakami S; Kamisuki S; Takata K; Kasai N; Kimura S; Mizushina Y; Ohta K; Sugawara F; Sakaguchi K
Biochem Biophys Res Commun; 2006 Nov; 350(1):7-16. PubMed ID: 16996474
[TBL] [Abstract][Full Text] [Related]
6. Sulfoquinovosylmonoacylglycerol inhibitory mode analysis of rat DNA polymerase beta.
Kasai N; Mizushina Y; Murata H; Yamazaki T; Ohkubo T; Sakaguchi K; Sugawara F
FEBS J; 2005 Sep; 272(17):4349-61. PubMed ID: 16128805
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structural model analysis of the binding site of an inhibitor, nervonic acid, of both DNA polymerase beta and HIV-1 reverse transcriptase.
Kasai N; Mizushina Y; Sugawara F; Sakaguchi K
J Biochem; 2002 Nov; 132(5):819-28. PubMed ID: 12417034
[TBL] [Abstract][Full Text] [Related]
8. Interaction model for anthracycline activity against DNA topoisomerase II.
Moro S; Beretta GL; Dal Ben D; Nitiss J; Palumbo M; Capranico G
Biochemistry; 2004 Jun; 43(23):7503-13. PubMed ID: 15182192
[TBL] [Abstract][Full Text] [Related]
9. Symmetry and chirality in topoisomerase II-DNA crossover recognition.
Timsit Y; Duplantier B; Jannink G; Sikorav JL
J Mol Biol; 1998 Dec; 284(5):1289-99. PubMed ID: 9878350
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the lyase domain of human DNA polymerase lambda.
DeRose EF; Kirby TW; Mueller GA; Bebenek K; Garcia-Diaz M; Blanco L; Kunkel TA; London RE
Biochemistry; 2003 Aug; 42(32):9564-74. PubMed ID: 12911298
[TBL] [Abstract][Full Text] [Related]
11. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase.
Mizushina Y; Iida A; Ohta K; Sugawara F; Sakaguchi K
Biochem J; 2000 Sep; 350 Pt 3(Pt 3):757-63. PubMed ID: 10970789
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic DNA topoisomerase II beta.
Austin CA; Marsh KL
Bioessays; 1998 Mar; 20(3):215-26. PubMed ID: 9631649
[TBL] [Abstract][Full Text] [Related]
13. Kinetic mechanisms of rat polymerase beta-ssDNA interactions. Quantitative fluorescence stopped-flow analysis of the formation of the (Pol beta)(16) and (Pol beta)(5) ssDNA binding mode.
Jezewska MJ; Rajendran S; Galletto R; Bujalowski W
J Mol Biol; 2001 Nov; 313(5):977-1002. PubMed ID: 11700054
[TBL] [Abstract][Full Text] [Related]
14. Self-association and DNA binding properties of the human topoisomerase IIA alpha2HTH module.
Morant-Lhomel A; René B; Zargarian L; Troalen F; Mauffret O; Fermandjian S
Biochimie; 2006; 88(3-4):253-63. PubMed ID: 16213649
[TBL] [Abstract][Full Text] [Related]
15. Analysis of bisdioxopiperazine dexrazoxane binding to human DNA topoisomerase II alpha: decreased binding as a mechanism of drug resistance.
Renodon-Cornière A; Jensen LH; Nitiss JL; Jensen PB; Sehested M
Biochemistry; 2003 Aug; 42(32):9749-54. PubMed ID: 12911317
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling of four Y-family, lesion-bypass DNA polymerases: the case that E. coli Pol IV and human Pol kappa are orthologs, and E. coli Pol V and human Pol eta are orthologs.
Lee CH; Chandani S; Loechler EL
J Mol Graph Model; 2006 Sep; 25(1):87-102. PubMed ID: 16386932
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.
Sengupta T; Mukherjee M; Das A; Mandal C; Das R; Mukherjee T; Majumder HK
Biochem J; 2005 Sep; 390(Pt 2):419-26. PubMed ID: 15901238
[TBL] [Abstract][Full Text] [Related]
18. Repeated tertiary fold of RNA polymerase II and implications for DNA binding.
Fu J; Gerstein M; David PR; Gnatt AL; Bushnell DA; Edwards AM; Kornberg RD
J Mol Biol; 1998 Jul; 280(3):317-22. PubMed ID: 9665838
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of human DNA topoisomerase II activity by its direct association with the beta subunit of protein kinase CKII.
Park GH; Lee YT; Bae YS
Mol Cells; 2001 Feb; 11(1):82-8. PubMed ID: 11266126
[TBL] [Abstract][Full Text] [Related]
20. Theoretical model of restriction endonuclease HpaI in complex with DNA, predicted by fold recognition and validated by site-directed mutagenesis.
Skowronek KJ; Kosinski J; Bujnicki JM
Proteins; 2006 Jun; 63(4):1059-68. PubMed ID: 16498623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
